Valneva SE (VALN) Shares Outstanding (2019 - 2026)

Valneva SE (VALN) posted Shares Outstanding (Entity) of $84.1 million for Q4 2025, down 1.18% sequentially from $85.1 million in Q2 2025, and up 15.42% YoY from $72.9 million in Q4 2024.

Valneva SE (VALN) Shares Outstanding (2019 - 2026) Analysis & Trends

Valneva SE has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $84.1 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 15.42% year-over-year to $84.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $84.1 million (up 15.42% YoY) and the FY2025 annual result came in at $84.1 million, up 15.42% from the prior year.
  • Shares Outstanding (Entity) fell to $84.1 million in Q4 2025 per VALN's latest filing, from $85.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $85.1 million in Q2 2025 and troughed at $45.9 million in Q1 2021.
  • A 5-year average of $62.4 million and a median of $58.7 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) climbed 20.05% in 2023, then grew 5.11% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $48.8 million in 2021, then rose by 18.29% to $57.7 million in 2022, then climbed by 20.05% to $69.3 million in 2023, then grew by 5.11% to $72.9 million in 2024, then advanced by 15.42% to $84.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $84.1 million, $85.1 million, and $72.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Valneva SE 618.67 Mn 477.41 Mn 1.86 Mn 168.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 168.18 Mn
Mar 31, 2026 168.18 Mn
Dec 31, 2025 168.18 Mn
Sep 30, 2025 145.71 Mn
Jun 30, 2025 145.71 Mn
Mar 31, 2025 145.71 Mn
Dec 31, 2024 145.71 Mn
Sep 30, 2024 138.62 Mn
Jun 30, 2024 138.62 Mn
Mar 31, 2024 138.62 Mn
Dec 31, 2023 138.62 Mn
Sep 30, 2023 115.47 Mn
Jun 30, 2023 115.47 Mn
Mar 31, 2023 115.47 Mn
Dec 31, 2022 115.47 Mn
Sep 30, 2022 97.62 Mn
Jun 30, 2022 97.62 Mn
Mar 31, 2022 97.62 Mn
Dec 31, 2021 97.62 Mn
Sep 30, 2021 90.76 Mn